Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Ilian Iliev, CEO, NetScientific
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
NetScientific eyes opportunities after securing new capital
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Driving Total Shareholder Returns: Navigating the Mining Sector's Role in the Energy Transition and ESG Imperatives|Olivia Markham,Portfolio Manager, BlackRock2
00:10:00
Bossard Values & Guiding Principles: A Global Reformulation | Daniel Bossard - CEO of Bossard Group
00:10:00
Revolutionizing Marketing: Dai Nippon Printing Case Study
00:10:00
Cerberus Capital Management Becomes Significant Shareholder in Deutsche Bank
00:10:00
Economic Data Review and S&P 500 Earnings Highlights with Rob McDougle | Rob McDougle, Vice-President, Zhang Financial.
00:10:00
Interview with Ian Harris, President and CEO of Libero Copper & Gold
00:10:00
Analytical tools and techniques to reverse engineer and characterise the composition of reference products|Michael Kotsanis,CEO,Acrux Ltd
00:10:00
Maximizing Capital Gains Deferral: Advanced 1031 Exchange Strategies | KRISTOPHER (KRIS) SCHNELL - President & Founder of Cogent Independent Advisors, Inc.
00:10:00
A multifaceted game changer is the Dialight Ultra Efficient Vigilant LED High Bay | FARIYAL KHANBABI, CEO, Dialight PLC
00:10:00
US Gold Corp CEO George Bee speaks to Proactive's Thomas Warner at Resourcing Tomorrow 2023, Europe's largest mining event in London.|George Bee is CEO of US Gold Corp
00:10:00
BAUER Maschinen GmbH: Our steel heart | Peter Hingott, , BAUER Maschinen GmbH (TS)
00:00:00
Medlab Clinical talks upcoming Phase III NanaBis trial and NanoCelle partnering opportunities -Dr Sean Hall, CEO, Medlab Clinical Ltd